氯吡格雷抵抗与对策.pptVIP

下载本文档

17
0
约2.65万字
约 76页
2019-01-12 发布于浙江
举报
版权申诉

氯吡格雷抵抗与对策.ppt

1、本文档共76页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

434例患者CYP2C19等位基因频率分布 * 434例患者CYP2C19基因型频率分布不同性别CYP2C19基因型和等位基因频数频率分布 * 434例患者CYP2C19代谢型频率分布 * 血小板聚集的抑制: Onset References Gurbel PA, Bliden KP, Butler K, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of 替格瑞洛 versus 氯吡格雷 in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation. 2009;120:2577–2585. * In Period 1 (14 ± 2 days), the last dose of study drug was administered in the morning. In Period 2 (14 ± 2 days), all nonresponders switched treatment. All patients received concomitant aspirin therapy (75 to 100 mg once daily) in addition to study drug. Gurbel PA, Bliden KP, Butler K et al. Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies. The RESPOND Study. Circulation. 2010;121:1188–1199. * * 1. The CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502. 2. Plavix? (clopidogrel bisulfate) Prescribing Information. 所有 patients administered 替格瑞洛 exhibited a 10% absolute reduction in platelet reactivity compared with 75% of patients administered 氯吡格雷 (p=0.005)[Gurbel 2010:E] Only 13% of patients administered 氯吡格雷 achieved a 30% absolute reduction in platelet reactivity compared with 75% of patients administered 替格瑞洛 (p0.001)[Gurbel 2010:E] Reductions of 50% were only observed in patients administered 替格瑞洛 (13% vs. 0%; p=0.046)[Gurbel 2010:E] There was no interaction in treatment efficacy between centres (p=0.0998) or time of measurement (p=0.2429)[Gurbel 2010:F] Gurbel PA, et al. Circulation 2010;121:1188–1199. * 替格瑞洛 significantly reduced high platelet reactivity in a greater proportion of patients than 氯吡格雷[Gurbel 2010:Q] This difference was observed in comparisons with both 氯吡格雷反应者 and 无-反应者s The McNemar 无-parametric test was used to compare proportional data from matched pairs This is suitable for this pop